Goldenseal Sustainability & Cautions

Sustainability and Cautions — scientific infographic poster

Goldenseal (Hydrastis canadensis) is one of the most overharvested medicinal plants in North America — arguably the most overharvested woodland herb in the entire Western herbal tradition. CITES placed H. canadensis on Appendix II in 1997. The United Plant Savers organization lists goldenseal on its "At-Risk" register, the most urgent botanical conservation category. Twelve or more U.S. states list goldenseal as endangered, threatened, or vulnerable under state-level statutes. Wild populations have collapsed by approximately 50% over the past century, driven by the combination of intensive wildcrafting for the medicinal trade and the loss of the mature deciduous-forest habitat that goldenseal requires. Three points shape the ethical use of goldenseal today: cultivated and Forest Grown Verified material leaves wild populations untouched, while wild-crafted root draws on them; cheaper and more abundant berberine sources (Oregon grape, barberry, purified berberine hydrochloride (HCl)) cover the uses that do not depend on goldenseal's unique alkaloid profile; and the strict pregnancy/neonatal contraindications and the extensive drug-interaction profile make goldenseal one of the more hazardous "natural" herbs on the shelf. This deep-dive walks through the full conservation story, the decision framework for choosing between goldenseal and alternatives, the certification systems that allow ethical sourcing, and the complete safety profile.


Table of Contents

  1. A Century of Overharvest — How We Got Here
  2. CITES Appendix II Listing (1997)
  3. United Plant Savers "At-Risk" Designation
  4. State-Level Endangered, Threatened, and Vulnerable Listings
  5. The Habitat Problem — Mature Hardwood Forest Loss
  6. Cultivated vs Woods-Grown vs Wild-Crafted
  7. Forest Grown Verified (FGV) Certification
  8. Oregon Grape, Barberry, and Pure Berberine Hydrochloride as Alternatives
  9. How Goldenseal Compares With Other Berberine Sources, Use by Use
  10. Pregnancy, Breastfeeding, and Neonatal Contraindications
  11. Drug Interactions (CYP450 and P-Glycoprotein)
  12. Other Cautions (Hypertension, Hypoglycemia, Duration, Children)
  13. Sourcing Markers — Signs of Cultivated and of Wild-Harvested Goldenseal
  14. Key Research Papers
  15. Connections
  16. Featured Videos

A Century of Overharvest — How We Got Here

The decline of wild goldenseal is a multigenerational story that begins with the rapid adoption of Hydrastis canadensis by 19th-century American medicine. European settlers learned about goldenseal from Native American practitioners in the late 18th century. By the 1830s, the Eclectic physicians had elevated goldenseal to one of their most frequently prescribed remedies. By the 1850s, professional goldenseal "diggers" were systematically combing the Appalachian and Ozark hardwood forests for marketable wild root, supplying a national trade that increasingly exported to Europe.

The pressure on wild populations intensified through several waves:

The cumulative effect of nearly 200 years of intensive wild harvest, layered onto the parallel loss of mature deciduous-forest habitat across the eastern United States, has produced documented declines of 50% or more in wild population density across goldenseal's native range. The species is not extinct in the wild, but it is significantly more rare than it was a century ago, and remaining wild populations are concentrated in increasingly fragmented forest patches.

Back to Table of Contents

CITES Appendix II Listing (1997)

The Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) is a multilateral treaty, in force since 1975 and now with 185 parties, that regulates international trade in species whose survival is threatened by commercial trade. Species are listed on one of three Appendices according to the level of protection required.

Appendix I includes species threatened with extinction; international commercial trade is generally prohibited.

Appendix II includes species not necessarily threatened with extinction but in which trade must be controlled to ensure that wild populations are not threatened. Trade is allowed but only with CITES-issued export permits, and the exporting country must conclude (and document) that the export is not detrimental to the species' survival.

Appendix III includes species protected in at least one country which has asked other CITES parties for assistance in controlling trade.

Hydrastis canadensis was added to CITES Appendix II at the Tenth Conference of the CITES Parties in June 1997 (effective September 18, 1997), on a proposal submitted by the United States; the U.S. Fish and Wildlife Service cites concern about over-collection of wild goldenseal in the United States and Canada, where the plant grows. The listing was motivated by documented declines in wild populations, the increasing volume of international trade (particularly to European, Asian, and other markets), and the difficulty of distinguishing cultivated from wild-harvested material once roots had been dried and processed.

Practical effects of the CITES listing:

The CITES listing has been broadly successful in slowing the international export trade of wild goldenseal, though it has not eliminated the domestic US wild-harvest pressure on the remaining wild populations.

Back to Table of Contents

United Plant Savers "At-Risk" Designation

United Plant Savers (UpS) is a nonprofit organization founded in 1994 by herbalist Rosemary Gladstar and a coalition of botanical-medicine practitioners, conservationists, and academic ethnobotanists. Its mission is to protect native medicinal plants of North America and their natural habitats. The organization maintains two principal lists:

Hydrastis canadensis has been on the United Plant Savers "At-Risk" list since the organization's founding in 1994, and remains a centerpiece of UpS conservation advocacy. The organization operates the Goldenseal Botanical Sanctuary in Ohio — a 379-acre forest reserve dedicated specifically to protecting and propagating goldenseal and other at-risk woodland medicinals — and certifies certain cultivated suppliers as meeting UpS sustainability standards.

Other At-Risk species sharing the list with goldenseal include American ginseng (Panax quinquefolius), black cohosh (Actaea racemosa), blue cohosh (Caulophyllum thalictroides), bloodroot (Sanguinaria canadensis), echinacea species (E. angustifolia in particular), helonias root (Chamaelirium luteum), ladyslipper orchids, lomatium, osha, partridge berry, pink ladyslipper, ramps, sandalwood, slippery elm, sundew, trillium species, true unicorn, Venus flytrap, white sage, and wild yam. The breadth of the list reflects the broader crisis facing North American medicinal woodland flora.

The United Plant Savers framework offers consumers a clear ethical standard: prefer cultivated material from any At-Risk species, support Forest Grown Verified suppliers when available, and substitute non-threatened alternatives when therapeutically appropriate.

Back to Table of Contents

State-Level Endangered, Threatened, and Vulnerable Listings

In addition to the federal CITES listing, more than a dozen U.S. states have placed Hydrastis canadensis on state-level endangered, threatened, or vulnerable species lists. The specific designation varies by state, but the practical effect is restrictions or prohibitions on wild harvest, transportation, and sale of state-origin wild goldenseal.

States that list goldenseal as endangered, threatened, or otherwise of special conservation concern include:

The strongest wild populations of goldenseal remain in Kentucky, West Virginia, Indiana, southern Ohio, and parts of Virginia and Tennessee. Even in these strongholds, wild populations are under sustained pressure from continued commercial wild harvest, and regulatory frameworks vary in their enforcement effectiveness.

For buyers, the spread of state-level listings adds to the conservation case against wild-harvested goldenseal. The chain of custody of wild-harvested root is practically impossible to verify and the rules differ from state to state; cultivated material carries neither problem.

Back to Table of Contents

The Habitat Problem — Mature Hardwood Forest Loss

Beyond the direct harvest pressure on goldenseal populations, the broader threat is habitat loss. Hydrastis canadensis is a understory perennial that requires very specific growing conditions:

This habitat profile is essentially the inverse of what modern land-use trends have produced across the eastern United States. From 1800 to 1920, the original eastern hardwood forest was reduced by approximately 70% through clearing for agriculture and timber. From 1920 to present, regrowth has produced significant forest recovery in area but predominantly in the form of young, structurally simple, even-aged second-growth forest that lacks the mature canopy conditions goldenseal requires.

The current eastern US deciduous forest area is approximately 220 million acres, but mature (old-growth or near-old-growth) hardwood forest accounts for less than 1% of this total. Goldenseal's suitable habitat has been compressed into a small fraction of the area it occupied at European contact.

The habitat dimension of the goldenseal conservation problem is particularly significant because it cannot be reversed quickly. A clear-cut forest can theoretically be replanted, but the mature canopy + mycorrhizal community + soil profile + understory diversity that goldenseal requires takes 100-200 years to develop. A conservation strategy for goldenseal therefore involves not just protecting remaining wild populations and shifting to cultivated supply, but also long-term forest stewardship practices that allow mature forest conditions to gradually recover.

Back to Table of Contents

Cultivated vs Woods-Grown vs Wild-Crafted

The supply chain for medicinal goldenseal falls into three broad categories with very different sustainability profiles:

Wild-crafted (wild-harvested) — root dug from naturally occurring wild populations. This is the ethically problematic category. Even where wild harvest is legal under state law, it directly extracts from declining wild populations. There is no practical way for the consumer to verify that wild-harvested root was sustainably collected. Every purchase of wild-crafted root draws on wild stands that are already in decline.

Cultivated (field-grown) — root grown under artificial shade cloth, in raised beds with amended soil, on commercial farms. This is mass-produced cultivated supply, similar to most other commercial herbs. Alkaloid content can be acceptable but is typically lower than woods-grown or wild material because the artificial growing conditions do not perfectly reproduce the mature-forest microenvironment. Sustainable from a conservation perspective — no wild population is affected. The lower alkaloid content matters least where alkaloid concentration is not critical.

Woods-grown (also called "simulated wild" or "forest-cultivated") — root deliberately planted into existing mature hardwood forest understory under conditions that mimic wild growing habitat. The grower selects a suitable forest site, plants goldenseal rhizomes or seeds, manages light competition, and harvests after 4-8 years. Alkaloid content is comparable to wild-harvested material. It is the most sustainable form of goldenseal supply. Woods-grown systems also generate income from standing mature forest, creating economic incentives for landowners to preserve rather than clear-cut their forests.

In conservation terms the order is: woods-grown first, cultivated second, wild-crafted last. Suppliers of cultivated root typically document their sourcing on the label and on their website; when a vendor does not document where its goldenseal came from, the buyer has no way to tell cultivated from wild-harvested root.

Woods-grown goldenseal comes from United Plant Savers-affiliated growers, specialty herb growers and herb farms, and seed suppliers (for home growers). A regional sustainable-development cooperative also coordinates woods-grown supply from a network of small-scale growers in the Appalachian region.

Back to Table of Contents

Forest Grown Verified (FGV) Certification

The Forest Grown Verified (FGV) program, a voluntary third-party verification process for forest-grown botanicals, was established in 2014 by a certification organization with the support of United Plant Savers; in the summer of 2019 control of the program passed to United Plant Savers. It addresses the cultivated-vs-wild supply chain ambiguity that complicates ethical goldenseal sourcing.

The FGV standard requires:

FGV-certified product is the most sustainably defensible goldenseal currently available in commercial supply. The certification is gradually becoming more common as both growers and consumers recognize the value of the chain-of-custody documentation. On a product label, FGV certification is the most specific marker of sustainable sourcing.

Other relevant certifications that may appear on goldenseal products:

Back to Table of Contents

Oregon Grape, Barberry, and Pure Berberine Hydrochloride as Alternatives

For the majority of clinical indications where goldenseal is considered, a more sustainable alternative is equally effective. The key sustainable alternatives:

Oregon grape (Mahonia aquifolium and related species) is the closest functional substitute for goldenseal. Native to the Pacific Northwest United States and southwestern Canada, Oregon grape is abundant in the wild and easily cultivated. Its root contains 2-3% berberine plus a distinct supporting alkaloid profile (berbamine, oxyacanthine) that provides efflux-pump inhibition and broader antimicrobial activity. For nearly all gut, urinary, and skin antimicrobial indications, Oregon grape root tincture or extract substitutes for goldenseal without therapeutic loss. Approximately 1/4 to 1/3 the cost of goldenseal per equivalent dose.

Barberry (Berberis vulgaris and related species) is a widely cultivated and naturalized shrub (introduced from Europe; some populations are considered invasive in parts of North America). The root and bark contain 1.5-3% berberine plus berbamine, palmatine, and jatrorrhizine. Similar therapeutic profile to Oregon grape. The fact that some North American barberry populations are managed as invasive species means that using barberry root is actively beneficial for habitat conservation in some regions.

Chinese goldthread (Coptis chinensis) contains the highest natural berberine concentration of any commonly available source (5-8%), and is the dominant source plant for commercial berberine hydrochloride extraction. Cultivated extensively in China; commercial supply is sustainably produced from cultivated stocks. Less commonly available in the Western herbal market in whole-plant form but very common as the source of commercial berberine extract.

Purified berberine hydrochloride (capsules) — the most economical and most precisely dosed option. Berberine extracted from Coptis or Phellodendron, purified to pharmaceutical-grade isolated compound, typically sold in 500 mg capsules at $0.10-0.30 per dose. For any indication where the primary effect is berberine (which is the majority of clinical applications), purified berberine hydrochloride delivers the same compound at a measured dose and the lowest cost. Free of sustainability concerns because the source plants are cultivated and the extraction is efficient.

The therapeutic comparison table:

Back to Table of Contents

How Goldenseal Compares With Other Berberine Sources, Use by Use

Putting the sustainability ethics together with the therapeutic alternatives, the uses fall into two groups:

Indications where the alternative berberine sources are equally or more effective (Oregon grape, barberry, or berberine hydrochloride serve the same purpose):

Indications where goldenseal's full alkaloid profile may be genuinely warranted (and where cultivated or FGV goldenseal is the form that spares wild stands):

The conservation-minded approach in this second group is cultivated or FGV-certified goldenseal at the minimum effective dose for the shortest effective duration. No use in either group depends on wild-crafted root, since woods-grown root has alkaloid content comparable to wild-harvested material.

In short, goldenseal fits the role of a specialized tool more than that of a general-purpose herbal antibiotic. For "antibiotic-like" general use, the alternatives are described as equally effective and are far more sustainable. For the narrow set of conditions where the unique alkaloid profile actually matters, cultivated goldenseal is the form that does not draw on wild stands.

Back to Table of Contents

Pregnancy, Breastfeeding, and Neonatal Contraindications

Goldenseal is ABSOLUTELY CONTRAINDICATED in pregnancy and breastfeeding, and in infants of any age.

The pregnancy contraindication is based on multiple distinct mechanisms, any one of which is a reason for concern on its own:

The lactation contraindication follows from the same mechanisms: berberine is excreted in breast milk in measurable concentrations, and the nursing infant's immature hepatic conjugation system cannot efficiently clear it. The concern therefore covers all berberine-containing products (goldenseal, Oregon grape, barberry, Chinese goldthread, purified berberine hydrochloride) during breastfeeding, and most of all in the immediate postpartum period.

The infant contraindication is absolute and covers all oral and topical goldenseal use under 2 years of age. The bilirubin displacement risk applies, and infant skin and mucous membranes also have higher absorption of topically applied compounds than adult skin. For infant infection or inflammation, safe pharmaceutical alternatives exist for essentially every indication.

Back to Table of Contents

Drug Interactions (CYP450 and P-Glycoprotein)

Goldenseal is one of the most drug-interaction-prone herbs in common use. Berberine is a potent inhibitor of multiple cytochrome P450 enzymes, which control the absorption, distribution, and clearance of a wide range of prescription drugs.

CYP450 enzyme inhibition — berberine inhibits:

Measured in people — in 16 healthy volunteers, 14 days of goldenseal raised blood levels of the test drug midazolam (a CYP3A probe) from 107.9 to 175.3 ng·h/ml (area under the curve) and lengthened its half-life from 2.01 to 3.15 hours (Gurley 2008). An earlier study in 12 healthy volunteers taking goldenseal for 28 days found about 40% inhibition of both CYP2D6 and CYP3A4/5 activity (Gurley 2005).

P-glycoprotein (P-gp) — P-gp is an efflux transporter in the gut wall and the blood-brain barrier. Drugs it carries include digoxin (a drug with a narrow therapeutic index), several chemotherapeutic agents (doxorubicin, paclitaxel, etoposide, vincristine), cyclosporine, tacrolimus, and others. In people, goldenseal had little measurable effect on it: in 20 healthy volunteers taking goldenseal (3,210 mg a day for 14 days), the only statistically significant change in digoxin was a 14% rise in its peak blood level, and the authors concluded that goldenseal is not a potent modulator of P-gp in the body (Gurley 2007). A 2021 study in 16 healthy volunteers found no effect of goldenseal on rosuvastatin or furosemide, two drugs carried by other transporters (Nguyen 2021).

Clinically significant interactions to flag:

In people, the measured effects are higher midazolam levels (CYP3A), about 40% inhibition of CYP2D6 and CYP3A4/5, and lower metformin exposure in healthy adults (see above). The interactions extend to all berberine sources — switching to Oregon grape, barberry, or purified berberine hydrochloride does not remove the drug-interaction profile; only the conservation cost differs.

Back to Table of Contents

Other Cautions (Hypertension, Hypoglycemia, Duration, Children)

Back to Table of Contents

Sourcing Markers — Signs of Cultivated and of Wild-Harvested Goldenseal

Markers of cultivated or forest-grown sourcing:

Warning signs of wild-harvested or adulterated product:

Suppliers of cultivated or FGV-certified goldenseal include specialty herb growers and herb farms, larger herbal-products companies (for specific products), and other suppliers explicitly affiliated with United Plant Savers or holding FGV certification.

For most clinical uses, purified berberine hydrochloride capsules are the cheapest form of berberine and free of sustainability concerns; goldenseal's full alkaloid profile is described as warranted only for a few narrow uses (see above).

Back to Table of Contents

Key Research Papers

  1. Gurley BJ, Gardner SF, Hubbard MA, et al. (2005). In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther — PubMed PMID: 15900287
  2. Gurley BJ, Swain A, Barone GW, et al. (2007). Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos — PubMed PMID: 17079360
  3. Gurley BJ, Swain A, Hubbard MA, et al. (2008). Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. Clin Pharmacol Ther — PubMed PMID: 17495878
  4. Nguyen JT, Tian DD, Tanna RS, et al. (2021). Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail. Clin Pharmacol Ther — PubMed PMID: 33174626
  5. Nguyen JT, Arian CM, Tanna RS, et al. (2025). The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent: A Three-Arm Crossover Study in Adults With Type 2 Diabetes. Clin Transl Sci — PubMed PMID: 39943692
  6. Jahnke GD, Price CJ, Marr MC, et al. (2006). Developmental toxicity evaluation of berberine in rats and mice. Birth Defects Res B Dev Reprod Toxicol — PubMed PMID: 16634078
  7. Chan E. (1993). Displacement of bilirubin from albumin by berberine. Biol Neonate — PubMed PMID: 8513024
  8. U.S. Fish and Wildlife Service (1999). Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES); Listing of Goldenseal (Hydrastis canadensis) in Appendix II and its Implementation by the United States; Public Meeting. Federal Register 64 FR 20320 — govinfo.gov
  9. CITES Appendix II listing of Hydrastis canadensis (1997) and ongoing trade monitoring — PubMed
  10. United Plant Savers At-Risk list methodology and goldenseal listing — PubMed
  11. Wild goldenseal population genetics and decline documentation — PubMed
  12. Woods-grown / forest-grown goldenseal cultivation methodology — PubMed
  13. Berberine drug interactions and CYP450 inhibition profile — PubMed
  14. Goldenseal effects on P-glycoprotein and drug transporter activity — PubMed
  15. Berberine teratogenicity and uterine contractile effects — PubMed
  16. Berberine displacement of bilirubin from albumin (neonatal kernicterus risk) — PubMed
  17. Berberine + warfarin pharmacokinetic interaction studies — PubMed
  18. Comparative phytochemistry of Hydrastis canadensis, Mahonia aquifolium, Berberis vulgaris, Coptis chinensis — PubMed
  19. Sustainable alternatives to At-Risk medicinal plants: the substitution framework — PubMed

PubMed Topic Searches

  1. PubMed: Goldenseal conservation
  2. PubMed: Woods-grown cultivation
  3. PubMed: Berberine drug interactions
  4. PubMed: Berberine pregnancy / neonatal
  5. PubMed: Sustainable berberine alternatives

Back to Table of Contents

Connections

Back to Table of Contents